FdaApplication
BLA 761194
Identifiers
- fda_app_no: BLA761194
Properties
| Property | Value |
|---|---|
| applicant_name | Genzyme Corporation |
| application_type | BLA |
| approval_date | 2021-08-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXVIAZYME | AVALGLUCOSIDASE ALFA-NGPT | 100MG | For Injection |
1 product